| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/10/2005 | US6890515 Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/10/2005 | US6890514 IGF-II greater than 29% above normal control value indicates that the subject has an increased risk of developing cervical cancer |
| 05/10/2005 | US6890486 For continuous on-line monitoring of water-borne organic contaminants |
| 05/10/2005 | US6890484 In line test device and methods of use |
| 05/10/2005 | US6890483 Non-luminescent substrate |
| 05/10/2005 | US6890426 Magnetic separation apparatus and methods |
| 05/10/2005 | US6890421 The analyte (blood or glcose) to be analyzed is allowed to react directly with an electrode, or with redox reagent |
| 05/10/2005 | US6890310 Adaptor for use with point-of-care testing cartridge |
| 05/10/2005 | US6890299 Method and apparatus for monitoring hemostasis in connection with artificial surface devices |
| 05/10/2005 | US6890291 Integrated automatic blood collection and processing unit |
| 05/10/2005 | US6889567 3D array integrated cells for the sampling and detection of air bound chemical and biological species |
| 05/10/2005 | US6889551 Method of estimating timber stiffness profiles |
| 05/10/2005 | CA2330935C A mutant human hepatitis b viral strain and uses thereof |
| 05/10/2005 | CA2132708C Fluorescence immunoassays using fluorescent dyes free of aggregation and serum binding |
| 05/10/2005 | CA2116559C Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 05/10/2005 | CA2116094C Microtitration unit |
| 05/10/2005 | CA2058344C Method and system for monitoring the admixing of fluent materials |
| 05/10/2005 | CA1341482C Process for preparing fragments of aids-associated retroviruses |
| 05/06/2005 | WO2005041212A2 Use of conductive or semi-conductive polymers in chemical sensors for detecting nitro compounds |
| 05/06/2005 | WO2005040835A2 Method for determining the antiradical defense potential and use thereof, in particular in veterinary and human preventive therapeutics |
| 05/06/2005 | WO2005040833A1 Regulation of human metastin recognising receptors |
| 05/06/2005 | WO2005040832A1 A rapid method of determining clearance of prion protein |
| 05/06/2005 | WO2005040831A1 Use of adam 12 for diagnosis and therapy of preeclampsia |
| 05/06/2005 | WO2005040830A1 Diagnostics and therapeutics for diseases associated with organic cationic transporter-like 3 (orctl3) (orctl3) |
| 05/06/2005 | WO2005040829A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 17 (gpr17) |
| 05/06/2005 | WO2005040828A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 49 (gpr49) |
| 05/06/2005 | WO2005040827A2 Diagnostics and therapeutics for diseases associated with organic cationic transporter-like 4 (orctl4) (orctl4) |
| 05/06/2005 | WO2005040826A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 64 (gpr64) |
| 05/06/2005 | WO2005040825A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20) |
| 05/06/2005 | WO2005040824A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 24 (gpr24) |
| 05/06/2005 | WO2005040823A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 15 (gpr15) |
| 05/06/2005 | WO2005040822A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 25 (gpr25) |
| 05/06/2005 | WO2005040821A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 18 (gpr18) |
| 05/06/2005 | WO2005040820A2 Methods for selecting compounds using antibodies with activity as antagonist, antagonist or allosteric modulators |
| 05/06/2005 | WO2005040819A1 Diagnostics and therapeutics for diseases associated with potent brain type organic ion transporter boct (boct) |
| 05/06/2005 | WO2005040818A2 Diagnostics and therapeutics for diseases associated with organic cation transporter flipt1 (flipt1) |
| 05/06/2005 | WO2005040817A1 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2 |
| 05/06/2005 | WO2005040816A1 Method of therapy |
| 05/06/2005 | WO2005040815A1 Method of detecting hepatitis c virus |
| 05/06/2005 | WO2005040814A1 Methods and means of cancer detection by histone modification |
| 05/06/2005 | WO2005040813A1 Xag protein in the in vitro diagnosis of pancreatic ductal adenocarcinoma |
| 05/06/2005 | WO2005040812A1 Use of protein ubc13 as a marker for breast cancer |
| 05/06/2005 | WO2005040811A1 Use of protein tip47 as a marker for breast cancer |
| 05/06/2005 | WO2005040810A1 Use of protein hnrnp-k as a marker for breast cancer |
| 05/06/2005 | WO2005040809A1 Use of protein hnrnp-f as a marker for breast cancer |
| 05/06/2005 | WO2005040808A1 Use of protein fkbp52 as a marker for breast cancer |
| 05/06/2005 | WO2005040807A2 Swiprosin-2 as a breast cancer marker |
| 05/06/2005 | WO2005040806A2 Use of protein asc as a marker for breast cancer |
| 05/06/2005 | WO2005040805A1 Use of protein masp as a marker for breast cancer |
| 05/06/2005 | WO2005040804A1 Use of protein spee as a marker for breast cancer |
| 05/06/2005 | WO2005040803A1 Diagnostics and therapeutics for diseases associated with solute carrier family 22 member 6 like 2 (slc22a6-like2) |
| 05/06/2005 | WO2005040802A2 Cylin binding peptides, and their use in drug screening assays |
| 05/06/2005 | WO2005040801A1 Reader for immunochromatographic test, cartridge applicable to this, and system for examining immunochromatographic test piece |
| 05/06/2005 | WO2005040800A1 Method for producing and using a new protein array, said protein array and the applications thereof |
| 05/06/2005 | WO2005040799A1 Artificial antibody comprising complementary peptide |
| 05/06/2005 | WO2005040798A1 Method of diagnosing alzheimer’s disease |
| 05/06/2005 | WO2005040797A1 Bio-assay substrate having a power supply wire configuration |
| 05/06/2005 | WO2005040796A1 Modulators of ms4a gene products |
| 05/06/2005 | WO2005040795A2 Diagnostics and therapeutics for diseases associated with aminopeptidase-like 1 (npepli) |
| 05/06/2005 | WO2005040794A2 Visual indicating device for bad breath |
| 05/06/2005 | WO2005040793A1 Meter and test sensor bank incorporating re-writable memory |
| 05/06/2005 | WO2005040792A2 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase (aminopeptidase b)-like 1 (rnpepl1) |
| 05/06/2005 | WO2005040791A2 Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) |
| 05/06/2005 | WO2005040790A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) |
| 05/06/2005 | WO2005040789A2 Diagnostics and therapeutics for diseases associated with putative organic ion transporter okb1 (okb1) |
| 05/06/2005 | WO2005040788A2 Method for measuring oils or fats, filtering apparatus for oils or fats, and measuring device |
| 05/06/2005 | WO2005040783A1 Novel sensor configuration |
| 05/06/2005 | WO2005040771A1 Fluorescence correlation spectroscopy with single excitation wavelength |
| 05/06/2005 | WO2005040759A2 Apparatus and methods for detecting target analyte |
| 05/06/2005 | WO2005040758A2 Use of pirfenidone in therapeutic regimens |
| 05/06/2005 | WO2005040755A2 Nanoscale transduction systems for detecting molecular interactions |
| 05/06/2005 | WO2005040754A2 METHOD AND KIT FOR DETECTING LISTERIA spp. |
| 05/06/2005 | WO2005040751A2 Decontamination and concentration kit for mycobacteria |
| 05/06/2005 | WO2005040741A1 Spectrophotometer |
| 05/06/2005 | WO2005040489A2 Fluorescent through-bond energy transfer cassettes based on xanthine and pyronin derivatives |
| 05/06/2005 | WO2005040422A2 Differentially expressed genes related to coronary artery disease |
| 05/06/2005 | WO2005040414A1 Methods and kits for investigating cancer |
| 05/06/2005 | WO2005040412A1 Detection method |
| 05/06/2005 | WO2005040409A2 Method for diagnosis of rheumatic diseases and agents for carrying out said diagnosis |
| 05/06/2005 | WO2005040406A1 High throughput screening of antibody libraries |
| 05/06/2005 | WO2005040405A2 Detecting microbial contamination in grain and related products |
| 05/06/2005 | WO2005040403A1 Method for detecting analytes by means of an analyte/polymeric activator bilayer arrangement |
| 05/06/2005 | WO2005040402A2 Diagnostics and therapeutics for diseases associated with n-acetylated alpha-linked acidic dipeptidase 2 (naaladase 2) |
| 05/06/2005 | WO2005040401A2 Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp) |
| 05/06/2005 | WO2005040399A2 Methods for quantitative determination of methylation density in a dna locus |
| 05/06/2005 | WO2005040351A2 Compositions for inducing cell growth and differentiation and methods of using same |
| 05/06/2005 | WO2005040347A2 Methods and compositions for inhibiting cell growth and proliferation |
| 05/06/2005 | WO2005040338A2 Constrained alkaloid immunogens and antibodies and uses thereof |
| 05/06/2005 | WO2005040337A2 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES |
| 05/06/2005 | WO2005040229A2 Ldl receptor class a and egf domain monomers and multimers |
| 05/06/2005 | WO2005040222A1 Monoclonal antibodies for detection of urinary trypsin inhibitors |
| 05/06/2005 | WO2005040219A1 Laminin-5 gamma2-binding peptides, related compositions, and use thereof |
| 05/06/2005 | WO2005040214A1 Virally-safe factor viii with a low content of higher multimers |
| 05/06/2005 | WO2005040211A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) |
| 05/06/2005 | WO2005040197A1 Compositions, methods and kits for biarsenical fluorophore labeling |
| 05/06/2005 | WO2005040196A2 Pif peptides biologic activities, site of action, and the antibody to detect pif |
| 05/06/2005 | WO2005040191A2 Ccn1 compositions and methods |
| 05/06/2005 | WO2005040111A2 Combinatorial library of 3-aryl-1h-indole-2-carboxylic acids |
| 05/06/2005 | WO2005040094A1 Novel dendrimer compound and a biochip using the same |
| 05/06/2005 | WO2005040073A2 Solid phase synthesis of 3-aryl-2- indolylcarboxylic acids |